SE8008952L - Forfarande och anordning for bestemning av serumlipoproteiner - Google Patents

Forfarande och anordning for bestemning av serumlipoproteiner

Info

Publication number
SE8008952L
SE8008952L SE8008952A SE8008952A SE8008952L SE 8008952 L SE8008952 L SE 8008952L SE 8008952 A SE8008952 A SE 8008952A SE 8008952 A SE8008952 A SE 8008952A SE 8008952 L SE8008952 L SE 8008952L
Authority
SE
Sweden
Prior art keywords
pct
enzyme
support
fixed
determination
Prior art date
Application number
SE8008952A
Other languages
English (en)
Other versions
SE450861B (sv
Inventor
L A Carlsson
L Holmquist
Original Assignee
Goella Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goella Lab filed Critical Goella Lab
Publication of SE8008952L publication Critical patent/SE8008952L/sv
Publication of SE450861B publication Critical patent/SE450861B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/97—Test strip or test slide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE8008952A 1979-05-02 1980-12-18 Forfarande och medel for bestemning av apolipoproteiner i serum SE450861B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7911082A FR2455743A1 (fr) 1979-05-02 1979-05-02 Procede et dispositif pour le dosage des lipoproteines seriques

Publications (2)

Publication Number Publication Date
SE8008952L true SE8008952L (sv) 1980-12-18
SE450861B SE450861B (sv) 1987-08-03

Family

ID=9224942

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8008952A SE450861B (sv) 1979-05-02 1980-12-18 Forfarande och medel for bestemning av apolipoproteiner i serum

Country Status (6)

Country Link
US (1) US4399217A (sv)
JP (1) JPS56500472A (sv)
FR (1) FR2455743A1 (sv)
GB (1) GB2061501B (sv)
SE (1) SE450861B (sv)
WO (1) WO1980002460A1 (sv)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2486657A1 (fr) * 1980-07-09 1982-01-15 Pasteur Institut Procede de detection et de dosage d'une substance biologique par erythroadsorption
DE3215310A1 (de) * 1982-04-23 1983-10-27 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
JPS58221166A (ja) * 1982-06-18 1983-12-22 Mochida Pharmaceut Co Ltd 免疫化学的測定用担体および該担体を使用した測定試薬
DE3319066A1 (de) * 1983-05-26 1984-11-29 Claus-Christian Dr.Rer.Nat. Dr.Med. 6901 Wilhelmsfeld Heuck Verfahren und reagenz zum direkten nachweis eines analyts nach spezifischer entfernung von colloidpartikeln in waessrigen loesungen biologischer herkunft
JPS6015559A (ja) * 1983-07-06 1985-01-26 Shiraimatsu Shinyaku Kk アポリポ蛋白−ｂの酵素免疫測定試薬
DE3338836A1 (de) * 1983-10-26 1985-05-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
US4654313A (en) * 1983-11-25 1987-03-31 The Washington University Methods for the determination of brain antigens
FR2560996B1 (fr) * 1984-03-09 1988-01-15 Commissariat Energie Atomique Procede de dosage immunologique d'antigenes, d'anticorps ou d'haptenes, son utilisation pour le dosage des lipoproteines et de l'a-foetoproteine et trousses de dosage pour la mise en oeuvre de ce procede
US4560504A (en) * 1984-12-06 1985-12-24 Uop Inc. Carboxyl anchored immobilized antibodies
US4970144A (en) * 1984-12-31 1990-11-13 International Genetic Engineering Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use
US4677057A (en) * 1985-03-11 1987-06-30 Scripps Clinic And Research Foundation Diagnostic assay for the presence of apolipoproteins associated with plasma high density lipoproteins
US4720455A (en) * 1985-09-06 1988-01-19 Pitman-Moore, Inc. Progesterone assay method for mammals and monoclonal antibody therefor
WO1988010430A1 (en) * 1985-12-27 1988-12-29 Arve Osland Determination of hdl2 and hdl3 concentration by use of extract from bacteria
AU7358187A (en) * 1986-04-11 1987-11-09 Murex Corp. Colorimetric ratioing immunoassay
IL79945A (en) * 1986-09-04 1991-06-10 I D L International Diagnostic Method for the quantitative determination of total cholesterol in blood
US5126240A (en) * 1986-09-29 1992-06-30 Curtiss Linda K Hybridomas and monoclonal paratopic molecules to apolipoprotein a-i
GB8717791D0 (en) * 1987-07-28 1987-09-03 Baralle F E Immunoassay method
WO1991002980A1 (en) * 1989-08-24 1991-03-07 Ramsey Foundation Method and apparatus for the measurement of organic antigens
US5344571A (en) * 1992-02-18 1994-09-06 University Of Texas System Board Of Regents Method for separating isoanalytes and measuring analytes in fluids
AUPN030794A0 (en) 1994-12-22 1995-01-27 Aruba International Pty Ltd Discontinuous plasma or serum delipidation
US7407663B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified immunodeficiency virus particles
US7407662B2 (en) 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified viral particles with immunogenic properties and reduced lipid content
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
US7439052B2 (en) * 2000-06-29 2008-10-21 Lipid Sciences Method of making modified immunodeficiency virus particles
US20090017069A1 (en) 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
US6991727B2 (en) * 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
AU2002322284A1 (en) * 2001-06-25 2003-01-08 Lipid Sciences, Inc. Systems and methods using multiple solvents for the removal of lipids from fluids
US20060060520A1 (en) * 2001-06-25 2006-03-23 Bomberger David C Systems and methods using a solvent for the removal of lipids from fluids
EP1409108A4 (en) * 2001-06-25 2007-11-14 Lipid Sciences Inc HOLLOW FIBER CONTACTOR SYSTEMS FOR THE REMOVAL OF LIPIDS FROM LIQUIDS
WO2003000373A1 (en) * 2001-06-25 2003-01-03 Lipid Sciences, Inc. Systems and methods using a solvent for the removal of lipids from fluids
JP2005538148A (ja) * 2002-08-26 2005-12-15 リピド サイエンスィズ インコーポレイテッド 脱脂タンパク質粒子を使用したアルツハイマー病治療
US7393826B2 (en) * 2003-07-03 2008-07-01 Lipid Sciences, Inc. Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
DK2368565T3 (en) * 2003-07-03 2015-09-28 Hdl Therapeutics Inc Enrichment of pre-beta lipoproteins, high density
US6960803B2 (en) * 2003-10-23 2005-11-01 Silicon Storage Technology, Inc. Landing pad for use as a contact to a conductive spacer
NZ570008A (en) 2006-02-09 2011-10-28 Univ South Florida Detection of ovarian cancer by elevated levels of Bcl-2 in urine
WO2009036168A2 (en) * 2007-09-11 2009-03-19 University Of Florida Research Foundation, Inc. Devices and methods for the collection and detection of substances
US9360398B2 (en) 2007-09-11 2016-06-07 University Of Florida Research Foundation, Inc. Devices and methods for the collection and detection of substances
US9207242B2 (en) 2008-10-09 2015-12-08 The University Of Hong Kong Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
WO2019104237A1 (en) 2017-11-22 2019-05-31 Hdl Therapeutics, Inc. Systems and methods for priming fluid circuits of a plasma processing system
CA3087207A1 (en) 2017-12-28 2019-07-04 Hdl Therapeutics, Inc. Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190496A (en) * 1971-05-14 1980-02-26 Syva Company Homogeneous enzyme assay for antibodies
US4002532A (en) * 1974-10-21 1977-01-11 Weltman Joel K Enzyme conjugates
NL7802056A (nl) * 1977-03-14 1978-09-18 Hoffmann La Roche Bepaling van menselijk (beta)-lipotropine.
IL51668A (en) * 1977-03-16 1981-12-31 Israel State Analytical method for the quantitative determination of immunogens and antibodies and a kit therefor
FR2385099A1 (fr) * 1977-03-21 1978-10-20 Stago Diagnostica Methode de determination immuno-enzymologique
US4230805A (en) * 1977-04-15 1980-10-28 Syva Company Theophylline antigens and antibodies
US4241177A (en) * 1978-08-28 1980-12-23 Syva Company Propanolol antigen conjugates and antibodies

Also Published As

Publication number Publication date
JPS56500472A (sv) 1981-04-09
GB2061501A (en) 1981-05-13
US4399217A (en) 1983-08-16
SE450861B (sv) 1987-08-03
WO1980002460A1 (fr) 1980-11-13
GB2061501B (en) 1983-09-14
FR2455743A1 (fr) 1980-11-28

Similar Documents

Publication Publication Date Title
SE8008952L (sv) Forfarande och anordning for bestemning av serumlipoproteiner
IL94087A0 (en) Methods,reagents and test kits for determining the presence or quantitiy of biological components in an analyzed sample
ES2153030T3 (es) Procedimiento de analisis cuantitativo del colesterol.
KR960702109A (ko) 대향 부품 크로마토그래피 분석장치
FI895505A0 (sv) Förfarande och reagensförpackning för bestämning av endotoxin eller ett ämne liknande endotoxin i ett prov samt monoklonala antikroppar att användas vid förfarandet
EP0384130A3 (en) Myocardial infarction immunoassay
ATE249049T1 (de) Verfahren zur bestimmung des prozentualen anteils von glykosiliertem hämoglobin
YU46053B (sh) Postopek za specifično določanje vsebnosti serumskega fruktozamina
GB2001172A (en) Competitive protein binding assay
ATE107418T1 (de) Nachweis von analyt in partikel enthaltenden proben.
KR900013307A (ko) 정량 크로마토그래피 방법 및 장치
ES8609723A1 (es) Procedimiento para la valoracion inmunologica de una subs- tancia, especialmente un antigeno un hapteno o un anticuerpo
Yakubu et al. Aflatoxin: Occurrence, regulation, and detection in food and feed
ATE113663T1 (de) Reagenz zum nachweis und zur quantitativen bestimmung von leukozyten in biologischen flüssigkeiten und verfahren zu seiner verwendung.
ATE88571T1 (de) Immunologischer testkit.
Gallati Interferon: a greatly simplified immuno enzyme determination with two monoclonal antibodies
NO175024C (no) Agglutineringsreagens og dets anvendelse for detektering av et antigen, antistoffer eller andre analytter, samt prövesett omfattende reagensen
Tuomola et al. Rapid time-resolved immunofluorometric assay for the measurement of creatine kinase in serum and whole blood samples
GB1508133A (en) Biological analysis
CN107860724A (zh) 一种基于光学生物传感器的沙丁胺醇检测方法
Willems et al. Measurement of total homocysteine concentrations in acidic citrate-and EDTA-containing tubes by different methods
ES2120888A1 (es) Metodo inmunoenzimatico cuantitativo para detectar la adulteracion de leche de oveja con leche de otra especie.
ATE140798T1 (de) Lipid-abhängige diagnostische analysenverfahren
KR970007350A (ko) 과량의 항원이 없는 단백질의 비탁 및 혼탁 측정법
Bossuyt Koenraad Gijbels Godelieve Mariën

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8008952-7

Effective date: 19900518

Format of ref document f/p: F